Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327 pISSN 1738-1088

Cited by CrossRef (9)

  1. Sadia Sultan. Treating Depression in Dementia Patients: A Risk or Remedy—A Narrative Review. Geriatrics 2024;9:64
    https://doi.org/10.3390/geriatrics9030064
  2. Francesco Weiss, Bruno Pacciardi, Giulia D’Alessandro, Valerio Caruso, Icro Maremmani, Stefano Pini, Giulio Perugi. The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature. JCM 2024;13:531
    https://doi.org/10.3390/jcm13020531
  3. Yasemin Hoşgören Alıcı, Müge Kuzu Kumcu. Potential Effect of Vortioxetine on Restless Leg Syndrome. Clin Psychopharmacol Neurosci 2023;21:599
    https://doi.org/10.9758/cpn.22.1021
  4. Eduardo Cumbo, Michael Adair, Daniel Oudin Åstrom, Michael Cronquist Christensen. Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea. Front. Aging Neurosci. 2023;14
    https://doi.org/10.3389/fnagi.2022.1037816
  5. Diego Santos García, Maria Gema Alonso Losada, Icíar Cimas Hernando, Iria Cabo López, Rosa Yáñez Baña, Ruben Alonso Redondo, Jose Manuel Paz González, Carlos Cores Bartolomé, Maria José Feal Painceiras, Maria Cristina Íñiguez Alvarado, Carmen Labandeira, Iago García Díaz. Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study. Brain Sciences 2022;12:1466
    https://doi.org/10.3390/brainsci12111466
  6. Alessandro Cuomo, Andrea Aguglia, Domenico De Berardis, Antonio Ventriglio, Camilla Gesi, Andrea Fagiolini. Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine. Ann Gen Psychiatry 2024;23
    https://doi.org/10.1186/s12991-024-00505-1
  7. Pedro J. Modrego, Leyre D. de Cerio, Antonio Lobo. The Interface between Depression and Alzheimer’s Disease. A Comprehensive Approach. 2023;26:315
    https://doi.org/10.4103/aian.aian_326_23
  8. Eric Lenouvel, Sebastian Tobias, Viktoria Mühlbauer, Dhayana Dallmeier, Michael Denkinger, Stefan Klöppel, Carlos Schönfeldt-Lecuona. Antidepressants for treating depression among older adults with dementia: A systematic review and meta-analysis. Psychiatry Research 2024;340:116114
    https://doi.org/10.1016/j.psychres.2024.116114
  9. Alessandro Padovani, Angelo Antonini, Paolo Barone, Giuseppe Bellelli, Andrea Fagiolini, Luigi Ferini Strambi, Sandro Sorbi, Fabrizio Stocchi. Exploring depression in Alzheimer’s disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management. Neurol Sci 2023;44:4323
    https://doi.org/10.1007/s10072-023-06891-w